Craig Coleman
Professor/Pharmacy Practice
Storrs Mansfield
Are you Craig Coleman?
How to update your information.
Scholarly Contributions
620 Scholarly Contributions
Rivaroxaban vs. warfarin and renal outcomes in non-valvular atrial fibrillation patients with diabetes.
2020
Research Type: Journal Article
Quality evaluation of case series describing four-factor prothrombin complex concentrate in oral factor Xa inhibitor-associated bleeding: a systematic review.
2020
Research Type: Journal Article
Identification and Outcomes of Hospitalized Medically Ill Patients Who Are Candidates for Extended Duration Thromboprophylaxis.
2020
Research Type: Journal Article
Comparative Effectiveness of Analgesics to Reduce Acute Pain in the Prehospital Setting.
2020
Research Type: Journal Article
Physicians' perspectives regarding non-medical switching of prescription medications: Results of an internet e-survey.
2020
Research Type: Journal Article
Burden-of-Illness Associated with Bleeding-Related Hospitalizations in Atrial Fibrillation Patients: Findings from the Nationwide Readmission Database.
2020
Research Type: Journal Article
Rivaroxaban Versus Warfarin for Management of Obese African Americans With Non-Valvular Atrial Fibrillation or Venous Thromboembolism: A Retrospective Cohort Analysis.
2020
Research Type: Journal Article
Effectiveness and safety of rivaroxaban compared with low-molecular-weight heparin in cancer-associated thromboembolism.
2020
Research Type: Journal Article
Rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism in African American patients: a retrospective cohort analysis.
2020
Research Type: Journal Article
Specialist physician perspectives on non-medical switching of prescription medications.
2020
Research Type: Journal Article
Rivaroxaban versus apixaban in non-valvular atrial fibrillation patients with end-stage renal disease or receiving dialysis.
2020
Research Type: Journal Article
Effectiveness and Safety of Rivaroxaban Versus Warfarin in Obese Nonvalvular Atrial Fibrillation Patients: Analysis of Electronic Health Record Data.
2020
Research Type: Journal Article
Four-year incidence of major adverse cardiovascular events in patients with atherosclerosis and atrial fibrillation.
2020
Research Type: Journal Article
Impact of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on renal and mortality outcomes in people with Type 2 diabetes and proteinuria.
2020
Research Type: Journal Article
Real-World Hemostatic Effectiveness of Andexanet Alfa for Management of Intracerebral Hemorrhage
2020
Research Type: Poster/Presentation
“OUTCOMES ASSOCIATED WITH BLEEDING-RELATED HOSPITALIZATIONS IN PATIENTS AT HIGH THROMBOTIC RISK FINDINGS FROM THE NATIONWIDE READMISSION DATABASE”. Event: ACC 2020, Chicago.
2020
Research Type: Poster/Presentation
Does Rivaroxaban Reduce the Development of Renal failure Compared to Vitamin K Antagonist Use in Nonvalvular Atrial Fibrillation Patients? A Systematic Review and Meta-Analysis
2020
Research Type: Poster/Presentation
Methodological and Reporting Quality in Case Series of Four-Factor Prothrombin Complex Concentrate in the Management of Oral Factor Xa Inhibitor-Associated Bleeding,
2020
Research Type: Poster/Presentation
Does one size fits all for NVAF patients with comorbidities?
2020
Research Type: Poster/Presentation